Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report

These are the first clinical data to indicate that the endocannabinoid system may be disturbed in affective disease, and suggest that future research is required to determine the relevance of these changes with respect to disease manifestation and pharmacotherapy.